Art
J-GLOBAL ID:201402224177989964   Reference number:14A0166786

Inhibition of Phosphate Transporters Ameliorates the Inflammatory and Necrotic Side Effects of the Nitrogen-Containing Bisphosphonate Zoledronate in Mice

マウスにおいて,リン酸輸送体の阻害は,窒素含有ビスホスホネート,ゾレドロネートの炎症性および壊死性副作用を改善する
Author (12):
Material:
Volume: 231  Issue:Page: 145-158 (J-STAGE)  Publication year: 2013 
JST Material Number: G0649A  ISSN: 0040-8727  CODEN: TJEMAO  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0166786&from=J-GLOBAL&jstjournalNo=G0649A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Basic research of other drugs acting on metabolism 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (52):
  • Adami, S. & Zamberlan, N. (1996) Adverse effects of bisphosphonate. A comparative review. <i>Drug Saf.</i>, 14, 158-170.
  • Anastasilakis, A.D., Goulis, D.G., Kita, M. & Avramidis, A. (2007) Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. <i>Hormones (Athens)</i>, 6, 233-341.
  • Anderson, C.M.H. & Thwaites, D.T. (2011) Hijacking solute carriers for proton-coupled drug transport. <i>Physiology</i>, 25, 364-377.
  • Buxton, I.L.O. (2006) Pharmakokinetics and pharmacodynamics: the dynamics of drug absorption, distribution, action, and elimination. In <i>Goodman and Gilman’s the pharmacological basis of therapeutics</i>, 11<sup>th</sup> edition, edited by Brunton, L.L., Lazo, J.S. & Parker, K.L. McGraw-Hill, New York, NY, pp. 1-39.
  • Chrisp, P. & Clissold, S.P. (1991) Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. <i>Drugs</i>, 41, 104-129.
more...

Return to Previous Page